ABAna Cecilia Bardan-Inchaustegui

Ana Cecilia Bardan-Inchaustegui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Cecilia Bardan-Inchaustegui has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Impact of Social Media and Artificial Intelligence on Illness Perception and Treatment Adherence in Patients With Rheumatic Diseases

    by Egla Samantha Sanchez-Peralta, Sharon Hervert-Bulbarella, Margarita Isabel Alarcon-Jarquin, Ana Cecilia Bardan-Inchaustegui, Angel Kevin Garza-Elizondo, Pablo Gamez-Siller, Jesus Alberto Cardenas-De la Garza, Dionicio Angel Galarza-Delgado, Diana Elsa Flores-Alvarado

    Background/Objective: In the wake of the COVID-19 “infodemic,” patients increasingly turn to social media (SM) and artificial intelligence (AI) for health information. In regions with unique sociocultural challenges and varying education levels, understanding electronic health literacy (HL) is vital. This study evaluated engagement with and attitudes toward SM/AI among patients with rheumatology conditions to inform patient-centered care. Methods: We conducted an observational, cross-sectional study at a tertiary outpatient clinic in Monterrey, Mexico, from August 2024 to November 2024. Ninety-five adult patients (median age: 50; 92.6% females) completed a structured questionnaire comprising the eHealth Literacy Scale (eHEALS), the SM Engagement Questionnaire (SMEQ), and the AI Attitude Scale (AIAS-4). Comparisons between age groups (≤45 vs. >45 y) were performed using the χ 2 test and the Mann-Whitney U test ( p < 0.05). Results: Daily SM use was almost universal (94.7%), and 30.5% had used AI for disease-related questions. Patients aged 45 or younger showed significantly higher electronic HL ( p = 0.010) and engagement with SM ( p < 0.001). Importantly, younger patients were less likely to change their treatment based on SM content compared with older patients ( p = 0.043). Although attitudes toward AI did not vary by age, 84.2% of patients believed their doctors were open to discussing digital information, and 91.6% would use SM if recommended by their physicians. Conclusions: Digital health literacy significantly influences how patients process online information and manage treatment adherence.

  • Associations between SARC-F score and FRAX score in patients with rheumatoid arthritis: A cross-sectional study

    by Ana Cecilia Bardan-Inchaustegui, Braulio Rafael Avalos-Garcia, Valeria Saulit Narvaez-Gonzalez, Daniel Rodríguez-Garibay, Carolina Treviño-Sánchez, Valeria Ortiz-González, Valeria Monserrat de Hoyos-Perez, Roberto Negrete-Lopez, Lorena Perez-Barbosa, Jesus Alberto Cardenas-De la Garza, et al.

    Introduction Rheumatoid arthritis (RA) increases the risk of osteoporotic fractures due to chronic inflammation, glucocorticoid use, and reduced muscle mass. Sarcopenia, frequently underdiagnosed in RA, may contribute independently to skeletal fragility. This study aimed to determine the associations between sarcopenia risk, by the SARC-F screening tool, and 10-year fracture probability, calculated via FRAX, in patients with RA. Materials and methods A cross-sectional, retrospective study was conducted among 66 patients with RA aged ≥ 40 years in Mexico. Sarcopenia risk was assessed using the SARC-F questionnaire. Muscle mass was measured via dual-energy X-ray absorptiometry (DXA), and sarcopenia was defined according to EWGSOP2 criteria. Fracture risk was calculated using the Mexican FRAX tool. Four fracture risk scores were calculated: major osteoporotic and hip fracture risk, each assessed with and without bone mineral density (BMD). Results Sixty percent of participants were at high risk of sarcopenia (SARC-F ≥ 4), and 33.3% met EWGSOP2 sarcopenia criteria. SARC-F scores correlated negatively with femoral neck T-scores (r = -0.306, p = 0.013) and muscle mass (r = -0.390, p = 0.001). Significant weak-to-moderate positive correlations were observed between SARC-F and FRAX-predicted fracture risk (MOF-FRAX: r = 0.354 and 0.310; HF-FRAX: r = 0.294 and 0.267; all p < 0.05). SARC-F scores were significantly higher in patients classified as high fracture risk (p = 0.035). Conclusion Sarcopenia risk, as measured by SARC-F, is significantly associated with increased FRAX-estimated fracture risk in RA patients. Incorporating SARC-F into routine assessments may improve early identification of patients at high fracture risk. Key Points • Sarcopenia is common in rheumatoid arthritis and is frequently under-detected. • Higher sarcopenia risk is associated with poorer bone health and increased fracture probability. • Simple screening tools, such as SARC-F, may help identify RA patients at elevated fracture risk earlier in clinical practice.

  • Body image and sexual function in women with systemic lupus erythematosus: a cross-sectional study

    by Hector Alejandro Martinez-Espinosa, Luciana Yulliet Gaytan-Garcia, Juan Pablo Gonzalez-Morales, Arantza Michelle Nuñez-Elizondo, Regina Esdeyne Rivera-Villafuerte, Juan Angel Iii Garcia-Vargas, Maria Eugenia Corral-Trujillo, Gisela Garcia-Arellano, Ana Cecilia Bardan-Inchaustegui, Jesus Alberto Cardenas-De la Garza, et al.

    Systemic lupus erythematosus (SLE) is a unique experience for each patient, affecting physical, psychological, and social aspects. Furthermore, body image can be deteriorated. Although both dissatisfaction with body image and sexual dysfunction have been reported in SLE, their relationship remains unclear and has not been previously studied in a Mexican population. Our study aims to determine if body image is correlated with sexual function in women with SLE. A cross-sectional study was conducted in the rheumatology service including adult women aged 18 years or older who met the 2019 EULAR/ACR classification criteria for SLE. Participants completed the Body Esteem Scale (BES), Female Sexual Function Index (FSFI), Rosenberg Self-Esteem Scale (RSES) and Short Form-36 Health Survey (SF-36). All patients provided informed consent. Data from 68 women were analyzed. The mean age was 37.3 ± 13.4 years. Sexual dysfunction was prevalent in 57.4% (n = 39/68) of the participants. While no significant association was found between global body image (BES) and sexual function (r = 0.14, p = 0.24), the sexual attractiveness subdomain was significantly lower in women with dysfunction (3.22 vs. 3.66, p = 0.0125). In the multivariable logistic regression analysis, the primary independent predictors of sexual dysfunction were partner status (OR 0.12; 95% CI 0.02–0.49, p = 0.001), age (OR 1.09; 95% CI 1.02–1.17, p = 0.012), and self-esteem (OR 0.75; 95% CI 0.58–0.92, p = 0.018). Our findings may serve to improve treatment for patients with sexual dysfunction and SLE by offering therapies aimed at enhancing their self-esteem.


  • Association of diagnostic delay with disease activity and cumulative damage in Hispanic patients with idiopathic inflammatory myopathies: a cross-sectional study

    by Valeria Cantu-Martinez, Miguel A. Villarreal-Alarcon, Rebeca L. Polina-Lugo, Emmanuel Dominguez-Chapa, Ana C. Bardan-Inchaustegui, Dionicio A. Galarza-Delgado, Jesus Alberto Cardenas-De la Garza, Rosa I. Arvizu-Rivera

    Introduction Idiopathic inflammatory myopathies (IIM) are rare autoimmune disorders. Their clinical heterogeneity often leads to diagnostic delays, which have been associated with worse outcomes. In individuals with darker skin phototypes, cutaneous signs may be less apparent, further complicating recognition. We aimed to evaluate the association of diagnostic delay with disease activity and cumulative damage in patients with IIM. Method We conducted a cross-sectional, comparative study at a tertiary care hospital in Mexico from November 2024 to July 2025. Patients aged 18 years or older diagnosed with IIM were included and classified according to established criteria and a treating rheumatologist’s assessment. Data collected included demographics, comorbidities, skin phototype, and serology. Disease activity was measured using the myositis disease activity assessment tool which includes the Myositis Disease Activity Assessment Visual Analog Scale (MYOACT) and the Myositis Intention-to-Treat Activity Index (MITAX) and cumulative damage using the Myositis Damage Index (MDI). Patients were stratified by diagnostic delay, ≤ 5 months, and > 5 months. Statistical analysis included correlation tests and group comparisons. Results 53 patients were included, mean age of 45.3 years; 84.6% women. Dermatomyositis was the most frequent subtype (62.2%). Patients with diagnostic delay > 5 months were significantly younger (p = 0.02) and showed higher disease activity (MYOACT p < 0.001; MITAX p = 0.005) and damage (MDI extent p = 0.03). Fitzpatrick phototypes IV–V were more prevalent among patients with longer diagnostic delays (80.7% p = 0.002 vs. 51.8% p = 0.002). Conclusion Longer diagnostic delays in IIM were associated with increased disease activity, functional impairment, and disproportionate impact on younger patients and those with darker skin tones. These findings highlight the need for earlier recognition and equitable diagnostic practices in diverse populations. Key Points •A diagnostic delay ≥ 5 months is associated with greater accumulated damage and disease activity. • A darker skin phototype and a younger age predispose to a longer diagnostic delay. • Delayed diagnosis was associated with worse physical function.